Martindale Pharma®, with roots tracing back to the 18th century, continues to be a leading UK manufacturer and supplier of injectables, oral solutions, suppositories and ophthalmic drops and ointments, for use by Healthcare professionals worldwide. Its products have been distributed in New Zealand by Max Health™ since 2009. In 2017 Martindale became part of Ethypharm Group. Ethypharm is active in over 50 different countries and is a key partner to the NHS in the UK. With the acquisition of Martindale, Ethypharm now have enhanced manufacturing capabilities and broader geographical reach. Products available in NZ include Acetylcysteine, Glycopyrronium and Clarithromycin injections.

Click here for more information on Ethypharm.

The Hameln group, based in Hameln Germany has over 100 years of company history behind it, having been run by the same family for four generations. It produces an outstanding range of injectable anaesthetic and intensive medicine products, in a state of the art sterile facility. Products approved and marketed in NZ include Dexamethasone, Amiodarone, and Rocuronium injections.

Click here for more information on Hameln.

Orion is an innovative European R&D based pharmaceutical and diagnostics company, based in Finland, with an emphasis on developing medicinal treatments and diagnostic tests for global markets. Orion has been “building well-being” for over 90 years and this continues with the company’s recent investment into the New Zealand market with its own Australia-NZ subsidiary. Max Heath will play a key role in Orion’s presence in the NZ market by remaining the exclusive distributor of Orion products here. Products currently supplied by Orion to NZ are Entacapone (Comtan) tablets, Levosimendan (Simdax) injection, and Estradiol (Sandrena) gel.

Click here for more information on Orion.

Alliance Pharmaceuticals is a leading international healthcare business based in Chippenham, UK. This strongly “values-driven” organisation is a true alliance of people, brands and parties working together to achieve more for patients. Alliance supply Tetracaine (Ametop) gel, Oxytocin and Ergometrine (Syntometrine) injection and Prochlorperazine (Buccastem) tablets.

Click here for more information on Alliance.

Born out of the pharmacy department of Torbay Hospital some 40 years ago, Torbay Pharmaceuticals has grown to become the largest NHS-owned contract manufacturer serving global markets.

As a semi-autonomous commercial business, wholly-owned by the Torbay and South Devon NHS Foundation Trust, it adheres to the ethical and quality standards laid down by the UK National Health Service. Its profits are re-invested to support the local healthcare community, to continually improve quality and service delivery to customers, and to drive improvements in patient care across the UK and other countries around the world, including New Zealand. It currently supplies Metaraminol injection to Max Health™ NZ.

Click here for more information on Torbay.

Generic Health was founded in 2004 and has since grown to be a leading company in generic pharmaceuticals in Australia. Since its founding it has acquired a number of suppliers and brands, allowing for a diverse portfolio of therapeutics. In 2012 Generic Health were acquired by Lupin, enabling further growth and expansion. Generic Health supplies all three strengths of Octreotide injection to Max Health.

Click here for more information on Generic Health.

Flynn Pharma is a privately owned British company that supplies pharmaceuticals in a number of key therapeutic areas including psychiatry, pediatrics, post-operative pain management and emergency medicine. It prides itself on its reliability of supply coupled with a commitment to provide further education and resources for both patients and healthcare professionals. Flynn currently supplies Cefalexin oral granules to Max Health, and we are looking to further expand this portfolio.

Click here for more information on Flynn Pharma.

Based in Australia, Orpharma is a pharmaceutical company with a focus on niche, orphan, and emerging therapies, pharmaceuticals and devices alike. Its partnerships with leading global pharmaceutical and biotechnology companies allow it to provide innovative medicines targeting rare metabolic diseases, specific cancers and other rare disorders. Orpharma’s presence remains predominantly in Asia Pacific, the MENA region and Eastern Europe. It supplies Pheburane granules and Isoprenaline 1mL Injection to Max Health.

Click here for more information on Orpharma.

Wockhardt manufactures many injectable products in their facility in Wrexham, UK.  It provides Levomepromazine injection and Sulfadiazine tablets to Max Health™.

Click here for more information on Wockhardt.

Kyowa Kirin - United Kingdom

Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. Their core therapeutic areas include oncology, nephrology, immunology/allergy and the central nervous system. Kyowa Kirin International plc supplies Pabrinex injection to Max Health.

Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical company.

Click here for more information on Kyowa Kirin International.